Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eugenia Guerzoni"'
Autor:
Teresa M. Seccia, Brasilina Caroccia, Francesca Gioco, Maria Piazza, Valentina Buccella, Diego Guidolin, Eugenia Guerzoni, Barbara Montini, Lucia Petrelli, Elisa Pagnin, Verdiana Ravarotto, Anna S. Belloni, Lorenzo A. Calò, Gian Paolo Rossi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 7 (2016)
BackgroundTubulointerstitial fibrosis, the final outcome of most kidney diseases, involves activation of epithelial mesenchymal transition (EMT). Endothelin‐1 (ET‐1) activates EMT in cancer cells, but it is not known whether it drives EMT in the
Externí odkaz:
https://doaj.org/article/ff41e15239f54c0faafbd589989fa82f
Autor:
Valentina Buccella, Elisa Pagnin, Verdiana Ravarotto, Diego Guidolin, Francesca Gioco, Barbara Montini, Brasilina Caroccia, Lucia Petrelli, Teresa Maria Seccia, Eugenia Guerzoni, Gian Paolo Rossi, Lorenzo A. Calò, Anna S. Belloni, Maria Piazza
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Tubulointerstitial fibrosis, the final outcome of most kidney diseases, involves activation of epithelial mesenchymal transition (EMT). Endothelin‐1 (ET‐1) activates EMT in cancer cells, but it is not known whether it drives EMT in the
Autor:
Teresa Maria Seccia, Brasilina Caroccia, Francesca Gioco, Maria Piazza, Valentina Buccella, Barbara Montini, Diego Guidolin, Eugenia Guerzoni, Elisa Pagnin, Verdiana Ravarotto, Lorenzo Calò, Anna Sandra Belloni, GianPaolo Rossi
Publikováno v:
Hypertension. 66
We tested the hypothesis that tubulo-interstitial fibrosis (TIF), the final outcome of most kidney diseases, involves activation of epithelial mesenchymal transition (EMT) through angiotensin II- and endothelin-1 (ET-1)-mechanisms. In a transgenic mo